Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives as Mnk inhibitors
Files
(Published version)
Date
2019
Authors
Abdelaziz, A.M.
Basnet, S.K.C.
Islam, S.
Li, M.
Tadesse, S.
Albrecht, H.
Gerber, C.
Yu, M.
Wang, S.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Bioorganic and Medicinal Chemistry Letters, 2019; 29(18):2650-2654
Statement of Responsibility
Conference Name
Abstract
Post-translational modulation of eIF4E through phosphorylation by Mnks is highly integral to the pathogenesis of different cancers. Therefore, inhibition of Mnks offers a strategy for cancer treatment. Herein, a series of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives is presented as Mnk inhibitors. Some of them showed sub-micromolar to low nanomolar inhibitory activities against Mnk1/2 with a high level of selectivity for both kinases over CDKs. Biochemical assays revealed that compounds 4c and 4t are non-ATP-competitive inhibitors of Mnks. Lead compound 4t demonstrated a high selectivity for Mnk1/2 over a selection of 51 kinases, and displayed anti-proliferative activities against a panel of cancer cell lines. However, this compound in combination with our in-house CDK4/6 inhibitor 83 did not show a synergistic effect in A2780 ovarian cancer cells, suggesting that caution be exercised in the selection of an agent to be combined with an Mnk inhibitor.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2019 Pergamon Press
Access Condition Notes: Accepted manuscript available after 1 July 2021